Alzamend Neuro, Inc. (ALZN)
1.00
-0.02
(-1.96%)
USD |
NASDAQ |
Apr 02, 09:36
Alzamend Neuro EPS Diluted (Quarterly) : -0.578 for Jan. 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Allogene Therapeutics, Inc. | -0.1717 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.199M |
| Total Expenses (Quarterly) | 2.199M |
| Enterprise Value | 1.164M |
| Earnings Yield | -455.0% |
| Normalized Earnings Yield | -455.01 |